Ipsen S.A.

€158.70As of Sun 8 Nov 2026, 12:00 UTC
EPA:IPNHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR 10.89%
Div yield 1.01%
ROE 11.44%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.32
PE TTM 25.72
TSR TTM 32.26%
Mkt cap €13.01B
ROIC 23.16%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€163
2.63%
(51.03%)
Hold 3|6|1|3|9
4Q25
1Q26
2Q26
3Q26
Earnings per share€
1.71
1.82
2.01
2.10
33.84%
27.16%
27.26%
37.03%
Revenue€B
1.057
1.051
1.093
1.156
3.61%
3.77%
2.85%
9.80%
Peers (US$14.61B)
Cap (US$)
PE
112.7B
24.22x
3.383B
19.35x
1.154B
16.23x
14.75B
18.94x
Capital
TTM
5Y
10Y
Leveragex
1.234
0.019
0.014
EBIT/Intx
0.559
0.142
0.125
Own earn%
61.12
108.72
76.74
Sh yield%
43.54
15.16
14.35
Owners
Insiders/Inst%
12.29
54.90
Short interest%
0.55
SBC / revenue%
2.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
12–17
$1 testx
−0.4
Incr. ROIC%
−3